A Reversal for MYMETICS CORPORATION (OTCMKTS:MYMX) Is Near. The Stock Has Decrease in Shorts

July 17, 2017 - By Maria Brooks

Investors sentiment is 0 in 2016 Q4. Its the same as in 2016Q3. It has no change, as 0 investors sold Mymetics Corp shares while 0 reduced holdings. only 0 funds opened positions while 0 raised stakes. 2.36 million shares or 50.00% less from 4.71 million shares in 2016Q3 were reported.
Iat Reinsurance Ltd holds 0.01% of its portfolio in Mymetics Corp (OTCMKTS:MYMX) for 2.19M shares. Tanaka Cap Incorporated, a New York-based fund reported 169,777 shares.

The stock of MYMETICS CORPORATION (OTCMKTS:MYMX) registered a decrease of 72.92% in short interest. MYMX’s total short interest was 1,300 shares in July as published by FINRA. Its down 72.92% from 4,800 shares, reported previously.

About 8.20M shares traded or 4697.17% up from the average. Mymetics Corp (OTCMKTS:MYMX) has 0.00% since July 17, 2016 and is . It has underperformed by 16.70% the S&P500.

Mymetics Corporation is a vaccine company. The company has market cap of $22.37 million. The Firm is focused on developing vaccines for infectious diseases. It currently has negative earnings. The Firm has over five vaccine candidates in its pipeline: human immunodeficiency virus type 1 /acquired immune deficiency syndrome (AIDS), intra nasal Influenza, Malaria, Herpes Simplex Virus (HSV) and the Respiratory Syncitial Virus (RSV) vaccine.

More notable recent Mymetics Corp (OTCMKTS:MYMX) news were published by: Upi.com which released: “HIV vaccine candidate shows promise with monkeys” on April 11, 2016, also Prnewswire.com with their article: “Astellas To Form Strategic Partnership With ClearPath To Build Vaccine Portfolio” published on January 06, 2014, Prnewswire.com published: “Mymetics and Texas Biomedical Research Institute Continue Collaboration on HIV …” on September 19, 2016. More interesting news about Mymetics Corp (OTCMKTS:MYMX) were released by: Businesswire.com and their article: “Global Genital Herpes Pipeline Report 2016 – Research and Markets” published on March 30, 2016 as well as Prnewswire.com‘s news article titled: “Mymetics Starts Research Project with Sanofi for Influenza Vaccines” with publication date: December 01, 2016.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.